Shandong Realcan Pharmaceutical Co Ltd (002589) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Shandong Realcan Pharmaceutical Co Ltd (002589) has a cash flow conversion efficiency ratio of -0.003x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-15.60 Million ≈ $-2.28 Million USD) by net assets (CN¥5.45 Billion ≈ $798.12 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Shandong Realcan Pharmaceutical Co Ltd for the company's overall valuation and market capitalisation.
Shandong Realcan Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2008–2025)
This chart illustrates how Shandong Realcan Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Shandong Realcan Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shandong Realcan Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Explore 002589 operating cash flow to net income to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
V-Mart Retail Limited
NSE:VMART
|
0.007x |
|
Zhejiang Unifull Industrial Fibre Co Ltd
SHE:002427
|
0.052x |
|
Jiangsu Rainbow Heavy Industries Co Ltd
SHE:002483
|
0.014x |
|
NICE Information Service Co. Ltd
KQ:030190
|
-0.030x |
|
Aeon Credit Service Bhd
KLSE:5139
|
-0.076x |
|
Hubei Biocause Heilen Pharmaceutical Co. Ltd.
SHE:301211
|
0.005x |
|
ZYLOX-TONBRDG.MED.TECH.H1
F:818
|
N/A |
|
Citic Guoan Wine Co Ltd
SHG:600084
|
0.005x |
Annual Cash Flow Conversion Efficiency for Shandong Realcan Pharmaceutical Co Ltd (2008–2025)
The table below shows the annual cash flow conversion efficiency of Shandong Realcan Pharmaceutical Co Ltd from 2008 to 2025. View 002589 share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥5.42 Billion ≈ $793.52 Million |
CN¥13.76 Million ≈ $2.01 Million |
0.003x | -90.99% |
| 2024-12-31 | CN¥5.69 Billion ≈ $833.30 Million |
CN¥160.44 Million ≈ $23.48 Million |
0.028x | +92.59% |
| 2023-12-31 | CN¥5.64 Billion ≈ $824.87 Million |
CN¥82.47 Million ≈ $12.07 Million |
0.015x | -83.91% |
| 2022-12-31 | CN¥5.75 Billion ≈ $841.67 Million |
CN¥523.07 Million ≈ $76.54 Million |
0.091x | +99.01% |
| 2021-12-31 | CN¥9.69 Billion ≈ $1.42 Billion |
CN¥442.95 Million ≈ $64.82 Million |
0.046x | +6.19% |
| 2020-12-31 | CN¥9.64 Billion ≈ $1.41 Billion |
CN¥414.96 Million ≈ $60.72 Million |
0.043x | -78.93% |
| 2019-12-31 | CN¥10.25 Billion ≈ $1.50 Billion |
CN¥2.09 Billion ≈ $306.49 Million |
0.204x | +1245.34% |
| 2018-12-31 | CN¥11.31 Billion ≈ $1.65 Billion |
CN¥-201.66 Million ≈ $-29.51 Million |
-0.018x | +92.88% |
| 2017-12-31 | CN¥9.67 Billion ≈ $1.42 Billion |
CN¥-2.42 Billion ≈ $-354.40 Million |
-0.250x | -6.78% |
| 2016-12-31 | CN¥7.50 Billion ≈ $1.10 Billion |
CN¥-1.76 Billion ≈ $-257.40 Million |
-0.234x | -71.19% |
| 2015-12-31 | CN¥3.40 Billion ≈ $498.16 Million |
CN¥-466.26 Million ≈ $-68.23 Million |
-0.137x | -52.79% |
| 2014-12-31 | CN¥1.83 Billion ≈ $267.10 Million |
CN¥-163.62 Million ≈ $-23.94 Million |
-0.090x | +46.11% |
| 2013-12-31 | CN¥1.65 Billion ≈ $241.45 Million |
CN¥-274.46 Million ≈ $-40.16 Million |
-0.166x | +10.61% |
| 2012-12-31 | CN¥916.39 Million ≈ $134.10 Million |
CN¥-170.52 Million ≈ $-24.95 Million |
-0.186x | +67.99% |
| 2011-12-31 | CN¥817.11 Million ≈ $119.57 Million |
CN¥-475.03 Million ≈ $-69.51 Million |
-0.581x | -343.92% |
| 2010-12-31 | CN¥296.03 Million ≈ $43.32 Million |
CN¥70.56 Million ≈ $10.32 Million |
0.238x | -9.07% |
| 2009-12-31 | CN¥234.18 Million ≈ $34.27 Million |
CN¥61.38 Million ≈ $8.98 Million |
0.262x | +158.80% |
| 2008-12-31 | CN¥111.89 Million ≈ $16.37 Million |
CN¥-49.88 Million ≈ $-7.30 Million |
-0.446x | -- |
About Shandong Realcan Pharmaceutical Co Ltd
Realcan Pharmaceutical Group Co., Ltd. sells medicines, medical devices, and medical consumables to medical institutions in China. It operates through the Drug and Equipment Distribution, In Vitro Diagnostics, Pharmaceutical Logistics, Traditional Chinese Medicine, and Microbiome Medicine segments. The company engages in the processing, manufacture, sale, and wholesale of Chinese medicinal materi… Read more